Inflammation  >>  Soliris (eculizumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Soliris (eculizumab) / AstraZeneca
2017-004307-51: Inflammation inhibitors to reduce brain injury after a hemorrhagic stroke. Ontstekingsremmers om schade na bloeding tussen hersenvliezen te verminderen.

Ongoing
2
40
Europe
Powder for infusion, Soliris
University Medical Center Utrecht, ZonMW/Hersenstichting, Alexion Pharmaceuticals
Aneurysmal subarachnoid hemorrhage Aneurysmatische subarachnoïdale bloeding, Stroke Hersenvliesbloeding, Diseases [C] - Cardiovascular Diseases [C14]
 
 

Download Options